Status:
COMPLETED
COVID-19 Progression in End-Stage Kidney Disease
Lead Sponsor:
Davita Clinical Research
Conditions:
SARS-CoV-2 Infection (Asymptomatic)
SARS-CoV-2 Infection (Symptomatic)
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to collect genomic and clinical data among a cohort of hemodialysis patients and analyze the association between genetic markers and the development and severity of illnes...
Detailed Description
COVID-19 is a novel illness caused by the SARS-CoV-2 virus. It was declared as a global pandemic on March 11, 2020 and since that time there have been outbreaks on every continent except for Antarctic...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Is 18 years or older at the time of consent
- Ability to provide informed consent.
- Is currently receiving hemodialysis treatment for end-stage kidney disease at a DaVita dialysis center.
- Enrollment in prior genomics study (Additional criteria for type B only)
Exclusion
Key Trial Info
Start Date :
August 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT04495907
Start Date
August 6 2020
End Date
August 31 2021
Last Update
March 22 2022
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
DCR Victorville
Victorville, California, United States, 92394
2
DCR Connecticut
Bridgeport, Connecticut, United States, 06606
3
DCR Twin Cities
Minneapolis, Minnesota, United States, 55404
4
DCR Las Vegas
Las Vegas, Nevada, United States, 89128